Skip Navigation LinksHome > Press

For Immediate Release
September 26, 2016
AABB Communications Department
Magda Yang
Office: +1.301.215.6569
Contact:
Transfusion Medicine, Cellular Therapies and Patient Blood Management Professionals Gather in Orlando for AABB Annual Meeting
MEDIA ADVISORY
WHAT:2016 AABB Annual Meeting
WHEN:Saturday, Oct. 22 - Tuesday, Oct. 25, 2016
WHERE:Orange County Convention Center
9800 International Drive
Orlando, FL 32819
Educational programs and discussions will include:

Hot Topic: Zika and Its Impact to Transfusion
With the demonstration of Zika virus RNA in blood donors, documented transfusion transmission, linkage to microcephaly, Guillain-Barré and other nervous system disorders, strategies are needed to protect the safety of the blood supply from this primarily mosquito-borne flavivirus. This session will describe the characteristics of the virus, its epidemiology, clinical outcomes associated with viral infection and public health considerations. Saturday at 2:00 p.m.

Clinical Practice Guidelines from the AABB: Red Blood Cell Transfusion Thresholds and Storage
Over 100 million units of blood are collected worldwide each year, yet the indication for Red Blood Cell (RBC) transfusion and RBC storage time remains uncertain. Large randomized clinical trials provide new evidence to guide RBC use. AABB recently published updated RBC transfusion guidelines. This session will present the randomized trial evidence and discuss the recommendations. Sunday at 2:00 p.m.

Karl Landsteiner Memorial Award and Lectureship
One of AABB’s most prestigious awards, the Karl Landsteiner Memorial Award goes to Stuart Orkin, MD, this year for his work to further understand hemoglobin disorders and his discovery of the first regulatory molecule, GATA-1, that mediates the development of specific types of blood cells from precursor cells. Dr. Orkin will lecture on the relevance of the human fetal-to-adult hemoglobin switch for the hemoglobin disorders. Tuesday at 8:30 a.m.

AABB Donor History Questionnaire
The implementation of FDA’s 2015 Final Rule (Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use) this year, prompted a full revision of the AABB Donor History Questionnaire (DHQ) and accompanying materials. During this session, members of the DHQ Task Force will share highlights of the revised DHQ, discuss issues posed by blood donation from transgender individuals and donor deferral for various medications. Sunday at 8:30 a.m.

Ask the FDA & CMS/CLIA
Always a popular session, regulatory experts from FDA and CMS CLIA field questions about regulations, guidance documents and inspection programs that are relevant to blood and HCT/P programs. AABB members submit their questions before the session via the AABB website. Monday at 4:30 p.m.

Review the Annual Meeting program here. At AABB’s sole discretion some sessions may be closed to the media.

Other highlights:
  • Opening Session will feature James Orbinski, MD, renowned physician and humanitarian, leading scholar in global health and recipient of the Nobel Peace Prize on behalf of Doctors Without Borders in 1999. 
  • Exhibit Hall opening on Saturday – featuring more than 200 exhibiting companies.


REGISTER HERE to receive a complimentary press registration. Contact the AABB Communications department via phone at +1.301.215.6526 or email at myang@aabb.org for additional information. More about the meeting can be found on the AABB website.

# # #